Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2014

Jardiance(Empagliflozin)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$11.43B

Medicare cost, 2024

Medicare drug plans spent $11.4 billion on Jardiance (empagliflozin) in 2024, for 11.4 million prescriptions and refills filled by 2.5 million patients. It ranks 3rd among all drugs by Medicare drug plan spending. Spending rose 29% from 2023 to 2024. California accounts for the most spending ($1.2 billion, 11% of the total).

Medicare cost, 2024

$11.43B

+29.4% from 2023

Prescriptions

11.4M

$1,005.97 per claim

Patients

2.5M

380,533 prescribers

Total spending, 2024

$11.44B

$4,496.46 per patient

Questions and answers

How much does Medicare spend on Jardiance?

Medicare prescription drug plans paid $11.43B for Jardiance in 2024, for 11,364,702 prescriptions and refills to 2,542,517 patients (up 29.4% from 2023). The average cost per claim was $1,005.97.

Which state spends the most on Jardiance?

California had the highest Medicare cost for Jardiance in 2024: $1.21B for 1,288,267 claims, followed by New York ($875.8M).

Who prescribes Jardiance the most?

Stella Ilyayeva, internal medicine in Rego Park, NY, had the highest Medicare cost for Jardiance in 2024: 5,520 claims costing $4.2M.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Jardiance was $11.44B in 2024, the highest year shown.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Jardiance, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Stella Ilyayeva Rego Park, NYInternal Medicine5,5201,051$4.2M
Eugenio Angueira-Serrano Miami, FLEndocrinology3,055671$2.6M
Bashar G Saad San Dimas, CAEndocrinology1,696433$1.5M
John T Funai Lihue, HICardiology1,030325$1.5M
Cheng-Yang C Tuan San Francisco, CAEndocrinology1,216288$1.5M
Lane M Frey Thibodaux, LAEndocrinology1,280288$1.4M
Eliscer Guzman New York, NYInternal Medicine1,326358$1.4M
Sharon H Kim Bronx, NYEndocrinology1,345326$1.4M
Wei Y Sun New York, NYNephrology2,074318$1.3M
Enrique J Griego McAllen, TXFamily Practice1,130335$1.3M
Mauricio Melhado West Palm Beach, FLCardiology1,732356$1.3M
1710074026 Internal Medicine1,242257$1.3M
Seshadri Das Staten Island, NYEndocrinology940294$1.3M
1982659660 Endocrinology1,686267$1.3M
Cres P Miranda Jr. Las Vegas, NVCardiology934320$1.3M
Helen L Slone Vineland, NJEndocrinology962287$1.2M
Mark T Hoffmann Wausau, WIInterventional Cardiology1,114268$1.2M
Ronak S Chaudhari Bowling Green, KYEndocrinology1,261278$1.2M
Monica G Robles Anniston, ALEndocrinology1,041270$1.2M
Abdul Al-Kassab Rochester Hills, MIEndocrinology856255$1.2M
Thomas-Duythuc to Reno, NVCardiology819274$1.1M
Mohammad T Ijaz Zanesville, OHEndocrinology1,182249$1.1M
Opada Alzohaili Dearborn, MIEndocrinology1,446297$1.1M
Joselito C Cabaccan San Jose, CAEndocrinology885277$1.1M
Ameya Hodarkar Burlington, MAEndocrinology1,069239$1.1M

Prescriber data by year

YearPrescribersClaimsPatientsCost
2022280,0365,651,5711,320,699$5.85B
2023336,8578,149,9651,881,944$8.84B
2024380,53311,364,7022,542,517$11.43B

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Boehringer Ing.11,368,280$11.44B

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
25
RxNorm concept IDs
1545658, 1545664, 1545666, 1545668
Application numbers
NDA204629

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube